Pleurodesis and Immunotherapy in NSCLC; Medical Thoracoscopy or VATS?
- PMID: 32047566
- PMCID: PMC6995373
- DOI: 10.7150/jca.40004
Pleurodesis and Immunotherapy in NSCLC; Medical Thoracoscopy or VATS?
Abstract
Introduction: Immunotherapy is a treatment option for non-small cell lung cancer advanced disease. However; immunotherapy in several patients induces orogonitis and effusion in different cavities. It is up to the treating physician to understand whether there is effusion due to adverse effect or disease progression. Pleurodesis in both cases might be a solution for recurrent pleura effusion. Patients and Methods: Three hundred and thirty seven non-small cell lung cancer patients with adenocarcinoma and pleura effusion during first line immunotherapy treatment underwent medical thoracoscopy or Video assisted thoracic surgery (VATS) for pleurodesis with talk poudrage. Uniportal medical thoracoscopy was performed under general with dual channel endotracheal tube in one hundred and eleven patients. Video assisted thoracic surgery was performed in one hundred and eighty seven patients and conversion from medical to VATS procedure was done to thirty nine patients. All patients had stage IV disease with pleura involvement and were under first line pembrolizumab treatment with 200mg (PD-L1 ≥ 50%). Results: The quantitative parameters of the study (expression, PY and cycle) were converted to an ordinal scale to facilitate the performance of statistical analysis. All parameters were examined as dependent against the parameter technique acting as independent to detect potential relationships. The results of multi Y versus X relationship revealed no statistically significant effect (p>0.05) of the three levels of technique against any response considered. Thus we can infer, quite safely, that the innovative operation (level 0) does not differ from the other two conventional methods (levels 2 and 3) through all parameters entered in the model. There was no significant difference between the different pleurodesis techniques. Discussion: Immunotherapy is known to induce in a number of patients pleura effusion and pericarditis. However; pleurodesis is efficient when the appropriate method is performed to every patient. Careful assessment in a case by case manner has to be performed for each patient before any procedure is performed.
Keywords: Medical Thoracoscopy; NSCLC; Pleurodesis; VATS.
© The author(s).
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
Figures




Similar articles
-
Cervical video-assisted thoracoscopic surgery using a flexible endoscope for bilateral thoracoscopy.Ann Thorac Surg. 2012 Apr;93(4):1321-3. doi: 10.1016/j.athoracsur.2011.11.068. Ann Thorac Surg. 2012. PMID: 22450093
-
Effectiveness and predictability of pleurodesis with the Tachosil® surgical patch compared with talc poudrage: an experimental study.Eur J Cardiothorac Surg. 2016 Oct;50(4):668-674. doi: 10.1093/ejcts/ezw118. Epub 2016 Apr 22. Eur J Cardiothorac Surg. 2016. PMID: 27107043
-
Malignant pleural effusion treatment outcomes: pleurodesis via video-assisted thoracic surgery (VATS) versus tube thoracostomy.Thorac Cardiovasc Surg. 2006 Aug;54(5):332-6. doi: 10.1055/s-2006-923931. Thorac Cardiovasc Surg. 2006. PMID: 16902882
-
Thoracoscopy: Advances and Increasing Role for Interventional Pulmonologists.Semin Respir Crit Care Med. 2018 Dec;39(6):693-703. doi: 10.1055/s-0038-1676978. Epub 2019 Jan 14. Semin Respir Crit Care Med. 2018. PMID: 30641587 Review.
-
Uniportal thoracoscopic surgery: from medical thoracoscopy to non-intubated uniportal video-assisted major pulmonary resections.Ann Cardiothorac Surg. 2016 Mar;5(2):85-91. doi: 10.21037/acs.2016.03.07. Ann Cardiothorac Surg. 2016. PMID: 27134833 Free PMC article. Review.
Cited by
-
Lung cancer biopsies: Comparison between simple 22G, 22G upgraded and 21G needle for EBUS-TBNA.J Cancer. 2020 Sep 14;11(21):6454-6459. doi: 10.7150/jca.48691. eCollection 2020. J Cancer. 2020. PMID: 33033529 Free PMC article.
References
-
- Du L, Herbst RS, Morgensztern D. Immunotherapy in Lung Cancer. Hematology/oncology clinics of North America. 2017;31(1):131–141. - PubMed
-
- Nanavaty P, Alvarez MS, Alberts WM. Lung cancer screening: advantages, controversies, and applications. Cancer control: journal of the Moffitt Cancer Center. 2014;21(1):9–14. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials